|
|
NPI Detail
NPI: 1760436216
Type: Organization
Taxonomy Code: 207P00000X
Physician/Emergency Medicine
Allopathic & Osteopathic Physicians/Emergency Medicine
22 XXXXXXXX XX
PORTLAND, ME 04102
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1760436216*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J0485
|
Belatacept injection
|
XXXXXX
|
$XXXXXX.XX
|
| J0256
|
Alpha 1 proteinase inhibitor
|
XXXXX
|
$XXXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J7192
|
Factor viii recombinant nos
|
XXXXX
|
$XXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J1459
|
Inj ivig privigen 500 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J0878
|
Daptomycin injection
|
XXXXX
|
-
|
| J1815
|
Insulin injection
|
XXXXX
|
-
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
| J8540
|
Oral dexamethasone
|
XXXXX
|
-
|
| J7179
|
Vonvendi inj 1 iu vwf:rco
|
XXXXX
|
-
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXXX
|
-
|
| J0185
|
Inj., aprepitant, 1 mg
|
XXXXX
|
$XXXXX.XX
|
| J2795
|
Ropivacaine hcl injection
|
XXXXX
|
-
|
| J2323
|
Natalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J2357
|
Omalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J2426
|
Inj, invega sustenna, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J0401
|
Inj aripiprazole ext rel 1mg
|
XXXXX
|
$XXXXX.XX
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J2182
|
Injection, mepolizumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J7195
|
Factor ix recombinant nos
|
XXXXX
|
$XXXXX.XX
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J1745
|
Infliximab not biosimil 10mg
|
XXXXX
|
$XXXXXX.XX
|
| J9034
|
Inj., bendeka 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J0690
|
Cefazolin sodium injection
|
XXXXX
|
-
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
